Post by IQVIA

Digital Health Technologies (DHTs) are advancing measurement science in CNS clinical trials. Explore how digital endpoints and biomarkers may improve sensitivity to change, enable longitudinal real-world data capture, and strengthen assessment of a patient’s function and quality of life in neurology and psychiatry. Download the white paper from IQVIA experts Bill Simpson, Salma Ajraoui, PhD, Aleksandra Sjöström-Bujacz and Stella Karantzoulis, PhD, ABPP-CN. https://lnkd.in/emsC2KRZ